142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

3129.0
Disparities in Cancer Screening, Diagnosis, and Treatment

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014: 10:30 AM - 12:00 PM
Oral
Cancer screening among vulnerable and underserved populations is a public health priority. Toward this end, this session will focus on a discussion of disparities in cancer screening including: geographic determinants of late-stage cancer at first diagnosis, the potential role of insurance mandates for reducing disparities, and social determinants of disparities. The identification of barriers to care among diverse groups will also be emphasized. The content of the session will be geared towards researchers and practitioners working in the area of cancer health disparities.
Session Objectives: Describe multilevel modeling methods using population health data to assess predictors of late-stage cancer at first diagnosis, including geographic disparities. Determine the impact of geographic location on advanced-stage ovarian cancer survival in relation to race and socioeconomic status. Identify racial and ethnic disparities in colorectal screening and discuss how insurance mandates may improve disparities. Examine the social determinants of health that contribute to cancer health disparities among underserved populations.

10:50am
Cancer disparities and health equity: Contributing regional factors among the underserved in MA
Joshua Nyambose, PhD, MALD, Gail Merriam, MSW, MPH, Terry Greene, M.S., Jacqueline Nolan, MPH, Karen Schneider, PhD, Lewis Holmes, MD, MPH, Gretchen Latowsky, MEd, Jane Hynson, BSPH and Xue Dai
11:10am
Impact of distance to care, race, and socioeconomic status on ovarian cancer survival in California: A spatial analysis
Robert Bristow, MD, MBA, Jenny Chang, MPH, Argyrios Ziogas, PhD, Lu Bai, MS, Daniel Gillen, PhD and Veronica Vieira, DSc

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Cancer Forum

See more of: Cancer Forum